Joint Commission CEO: Current quality improvements won’t get hospitals to zero harm

Mark Chassin Joint Commission ACHE

Mark Chassin, MD, MPH, MPP, president and CEO of The Joint Commission, speaking at the 2018 ACHE Congress in Chicago

In a presentation at the American College of Healthcare Executives (ACHE) Congress, Joint Commission president and CEO Mark Chassin, MD, MPP, MPH, made the case that creating a high-reliability organization with zero incidents of patient harm shouldn’t be seen as an abstract, aspirational goal.

Most women want a biopsy if there is any chance of breast cancer

Two out of three women want a biopsy performed if a radiologist determines there is any chance of breast cancer, according to a new study published in the Journal of the American College of Radiology. The authors also found that women overestimate the risk of breast cancer when follow-up imaging or biopsy is recommended for low-risk mammographic abnormalities.

DBT detects more architectural distortion lesions than 2D mammography alone

An example of architectural distortion in a 3D DBT mammogram, which is easier to see because the radiologist can look at the breast tissue layer-by-layer.

An example of architectural distortion in a 3D DBT mammogram, which is easier to see because the radiologist can look at the breast tissue layer-by-layer.

Digital breast tomosynthesis (DBT) can help radiologists detect more architectural distortion (AD) lesions than 2D mammography alone, according to a new study published in Radiology.